Literature DB >> 15622502

Renal tubular dysfunction in children with systemic lupus erythematosus.

Stephen D Marks1, Vanita Shah, Clarissa Pilkington, Patricia Woo, Michael J Dillon.   

Abstract

Renal tubular and glomerular function was studied in patients under 18 years of age with childhood-onset systemic lupus erythematosus (SLE) in relation to disease activity in two groups: patients with clinical or laboratory evidence of lupus nephritis and those without (lupus non-nephritis). We reviewed 11 patients with lupus non-nephritis and 10 patients with lupus nephritis over a 12-month period. The measured glomerular filtration rates had a tendency to be lower in the lupus nephritis group. Glomerular dysfunction was manifest in the lupus nephritis group with elevated urinary albumin/creatinine ratios (P <0.001). Markers of tubular function were measured and compared with data from 94 controls. The lupus nephritis group had elevated urinary NAG [N-acetyl-beta-D-glucosaminidase (P =0.001)] and RBP [retinol-binding protein (P =0.03)] levels. Tubular dysfunction with elevated urinary NAG levels was present in 2 lupus non-nephritis patients with no evidence of glomerular disease. The cohort of patients in this study was followed and 2 lupus non-nephritis patients with the highest urinary RBP levels developed evidence of glomerular dysfunction and biopsy-proven lupus nephritis. Evidence of tubular dysfunction in lupus non-nephritis patients may help to identify lupus nephritis prior to the onset of albuminuria.

Entities:  

Mesh:

Year:  2004        PMID: 15622502     DOI: 10.1007/s00467-004-1707-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  38 in total

1.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

2.  Renal tubular basement membrane changes in tubulointerstitial damage in patients with glomerular diseases.

Authors:  R Sinniah; T N Khan
Journal:  Ultrastruct Pathol       Date:  1999 Nov-Dec       Impact factor: 1.094

3.  Treatment of systemic lupus erythematosus in childhood.

Authors:  J C Jacobs
Journal:  Arthritis Rheum       Date:  1977-03

4.  Clinicopathologic correlations in lupus nephritis in Lima, Peru.

Authors:  A Hurtado; C Asato; E Escudero; C S Stromquist; J Urcia; M E Hurtado; S de La Cruz; M H Wener; R Zavala; R J Johnson
Journal:  Nephron       Date:  1999       Impact factor: 2.847

5.  Occurrence of renal tubular dysfunction in lupus nephritis.

Authors:  G A Kozeny; W Barr; V K Bansal; L L Vertuno; R Fresco; J Robinson; J E Hano
Journal:  Arch Intern Med       Date:  1987-05

6.  Proteinuria and tubulointerstitial lesions in lupus nephritis.

Authors:  G S Hill; M Delahousse; D Nochy; C Mandet; J Bariéty
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

7.  Nephritis in children and young adults with systemic lupus erythematosus and normal urinary sediment.

Authors:  A Woolf; B Croker; S G Osofsky; D W Kredich
Journal:  Pediatrics       Date:  1979-11       Impact factor: 7.124

8.  Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome.

Authors:  L B Tucker; S Menon; J G Schaller; D A Isenberg
Journal:  Br J Rheumatol       Date:  1995-09

9.  Toxicity of ifosfamide, cyclophosphamide and their metabolites in renal tubular cells in culture.

Authors:  M Mohrmann; S Ansorge; U Schmich; B Schönfeld; M Brandis
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

10.  Diagnostic value of urinary retinol-binding protein in childhood nephrotic syndrome.

Authors:  S C Dillon; G M Taylor; V Shah
Journal:  Pediatr Nephrol       Date:  1998-10       Impact factor: 3.714

View more
  8 in total

1.  Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis.

Authors:  Michael Zappitelli; Ciarán M Duffy; Chantal Bernard; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2007-10-24       Impact factor: 3.714

2.  Lupus nephropathy and cardiopulmonary and hepatic dysfunctions in a child.

Authors:  Wasiu Adekunle Olowu
Journal:  Pediatr Nephrol       Date:  2006-07-04       Impact factor: 3.714

Review 3.  Proteomic profiling of urine: implications for lupus nephritis.

Authors:  Najla Aljaberi; Michael Bennett; Hermine I Brunner; Prasad Devarajan
Journal:  Expert Rev Proteomics       Date:  2019-03-18       Impact factor: 3.940

4.  Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis.

Authors:  A Aggarwal; R Gupta; V S Negi; L Rajasekhar; R Misra; P Singh; V Chaturvedi; S Sinha
Journal:  Clin Exp Immunol       Date:  2017-02-23       Impact factor: 4.330

Review 5.  Use of biomarkers in the management of children with lupus.

Authors:  Elisabeth Binder; Monika Edelbauer
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

6.  Childhood-onset systemic lupus erythematosus.

Authors:  Wasiu Olowu
Journal:  J Natl Med Assoc       Date:  2007-07       Impact factor: 1.798

Review 7.  Urine biomarkers in juvenile-onset SLE nephritis.

Authors:  Louise Watson; Michael W Beresford
Journal:  Pediatr Nephrol       Date:  2012-05-16       Impact factor: 3.714

8.  Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Authors:  George K Bertsias; Maria Tektonidou; Zahir Amoura; Martin Aringer; Ingeborg Bajema; Jo H M Berden; John Boletis; Ricard Cervera; Thomas Dörner; Andrea Doria; Franco Ferrario; Jürgen Floege; Frederic A Houssiau; John P A Ioannidis; David A Isenberg; Cees G M Kallenberg; Liz Lightstone; Stephen D Marks; Alberto Martini; Gabriela Moroni; Irmgard Neumann; Manuel Praga; Matthias Schneider; Argyre Starra; Vladimir Tesar; Carlos Vasconcelos; Ronald F van Vollenhoven; Helena Zakharova; Marion Haubitz; Caroline Gordon; David Jayne; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2012-07-31       Impact factor: 19.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.